default author photo

Yu Qian

Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine

United States

SCHOLARLY PAPERS

1

DOWNLOADS

135

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

MAP4K1 Functions as a Tumor Promotor and Drug Mediator for AML via Modulation of DNA Damage/Repair System and MAPK Pathway

Number of pages: 28 Posted: 26 Jan 2021
Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University - Department of Hematology, Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Fudan University - Department of Neurology, Zhejiang University - Department of Hematology, Zhejiang University - Department of Hematology, Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University - Department of Hematology and Zhejiang University - Department of Hematology
Downloads 135

Abstract:

Loading...

Acute myeloid leukemia, MAP4K1, Homoharringtonine resistance, Prognosis, DNA damage, MAPK